These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9835519)

  • 1. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
    Tai CY; Escarpe PA; Sidwell RW; Williams MA; Lew W; Wu H; Kim CU; Mendel DB
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3234-41. PubMed ID: 9835519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
    Gubareva LV; Robinson MJ; Bethell RC; Webster RG
    J Virol; 1997 May; 71(5):3385-90. PubMed ID: 9094607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
    Mendel DB; Tai CY; Escarpe PA; Li W; Sidwell RW; Huffman JH; Sweet C; Jakeman KJ; Merson J; Lacy SA; Lew W; Williams MA; Zhang L; Chen MS; Bischofberger N; Kim CU
    Antimicrob Agents Chemother; 1998 Mar; 42(3):640-6. PubMed ID: 9517945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
    McKimm-Breschkin JL; Sahasrabudhe A; Blick TJ; McDonald M; Colman PM; Hart GJ; Bethell RC; Varghese JN
    J Virol; 1998 Mar; 72(3):2456-62. PubMed ID: 9499107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV; Webster RG; Hayden FG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
    McKimm-Breschkin JL; Blick TJ; Sahasrabudhe A; Tiong T; Marshall D; Hart GJ; Bethell RC; Penn CR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):40-6. PubMed ID: 8787876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
    Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Kati WM; Montgomery D; Carrick R; Gubareva L; Maring C; McDaniel K; Steffy K; Molla A; Hayden F; Kempf D; Kohlbrenner W
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1014-21. PubMed ID: 11897583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.
    Gubareva LV; Bethell R; Hart GJ; Murti KG; Penn CR; Webster RG
    J Virol; 1996 Mar; 70(3):1818-27. PubMed ID: 8627706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
    Smee DF; Sidwell RW; Morrison AC; Bailey KW; Baum EZ; Ly L; Wagaman PC
    Antiviral Res; 2001 Dec; 52(3):251-9. PubMed ID: 11675142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
    Gubareva LV; Webster RG; Hayden FG
    Antiviral Res; 2002 Jan; 53(1):47-61. PubMed ID: 11684315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
    Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
    Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
    Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.
    Bantia S; Ghate AA; Ananth SL; Babu YS; Air GM; Walsh GM
    Antimicrob Agents Chemother; 1998 Apr; 42(4):801-7. PubMed ID: 9559786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.